CluePoints Announces Amit Patel as New CFO
King of Prussia, PA: RBQM leader, CluePoints, has today announced that Amit Patel will join as the new Chief Financial Officer (CFO) amid ambitious growth plans and organizational changes as it continues to drive the paradigm shift in how world-class risk-based quality management (RBQM) and data quality oversight is delivered. With a projected outlook of a 25% […]
Citeline Finalist CluePoints Show Advanced AI Capabilities
King of Prussia, PA – March 23rd, 2023: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in Clinical Trials category. The award category recognizes companies, teams, or individuals leveraging artificial intelligence solutions to improve […]
Study shows KRIs improve data quality when used as part of a holistic RBQM plan
Authors: Steve Young, Chief Scientific Officer Sylviane de Viron, Data and Knowledge Manager In the face of ever-increasing clinical trial complexity, costs, and timelines, centralized monitoring can help sponsors reap the rewards of safer, more efficient drug development. Key risk indicators (KRIs) are an integral part of this approach, yet, to date, there has been […]
RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies
King of Prussia, PA – 6 February 2023: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, have announced a significant milestone today: they have de-risked over 1000 clinical studies. With over 6,000 platform users and more than 100,000 issues detected, CluePoints is proud to have been an integral player in the […]
CluePoints Appoints Andy Cooper as New Chief Executive Officer
King of Prussia, PA – December 13, 2022: RBQM leader, CluePoints, has today announced Andy Cooper has been appointed as its new Chief Executive Officer. Cooper succeeds Co-Founder, Francois Torche, who is stepping back as CEO to focus his full attention on the strategic direction of CluePoints’ world-leading product portfolio. Cooper has more than 24 years of clinical […]
RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials
King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions provider, CluePoints, is marking its tenth anniversary this year – placing it at the center of the journey from fledging concept to a fully realized, evidence-based methodology. The organization was just a year old when the US Food and Drug Administration (FDA) first recommended […]
Federated Learning & Risk-Based Data Management – The Future of Smart Healthcare
According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the application of machine learning (ML) in healthcare and clinical research.” Federated Learning (FL) is a method used for training Machine Learning models. It can decentralize the training process by providing access to data from multiple disparate sources without directly sharing […]
CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities
King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has won the Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities. The category recognizes the efforts of an individual, team, or company for innovative work in developing new treatments, […]
CluePoints Continues Impressive Global Growth with Three New Senior Appointments
King of Prussia, PA – April 5, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations. Catherine brings more than a decade of experience in the life science industry as a creative and insightful […]
UK Regulator Cites CluePoints’ Solutions in Updated Guidance
King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’ industry-leading statistical monitoring solutions. The document, Oversight and Monitoring Activities, covers a broad range of […]
